[1] Mazurek S, Boschek CB, Hugo F, et al. Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol, 2005, 15(4): 300-308.
[2] Hardt PD, Ewald N. Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancy. Expert Rev Mol Diagn, 2008, 8(5): 579-585.  doi: 10.1586/14737159.8.5.579
[3] Weinberger R, Appel B, Stein A, et al. The pyruvate kinase isoenzyme M2(Tu M2-PK) as a tumour marker for renal cell carcinoma. Eur J Cancer Care (Engl), 2007, 16(4): 333-337.  doi: 10.1111/j.1365-2354.2006.00753.x
[4] 丁志祥, 解东涯, 杨春秀, 等.血浆TU M2-PK检测对肺癌的诊断价值.第二军医大学学报, 2006, 27(2): 219-220.  doi: 10.3321/j.issn:0258-879X.2006.02.028
[5] Kumar Y, Tapuria N, Kirmani N, et al. Tumour M2-pyruvate kinase: a gastrointestinal cancer marker. Eur J Gastroenterol Hepatol, 2007, 19(3): 265-276.  doi: 10.1097/MEG.0b013e3280102f78
[6] 禹立霞, 刘宝瑞, 王立峰, 等.胃肠肿瘤术后Tu M2-PK含量的变化.实用医技杂志, 2006, 13(3): 350-352.  doi: 10.3969/j.issn.1671-5098.2006.03.013